Atomo Diagnostics Limited (ASX:AT1)
Australia
· Delayed Price · Currency is AUD 0.0390
+0.0010 (2.63%)
At close: Mar 5, 2026
Atomo Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2017 |
| Revenue | 3.92 | 3.79 | 4.09 | 2.54 | 12.34 | 6.72 | Upgrade
|
| Revenue Growth (YoY) | -7.00% | -7.20% | 60.65% | -79.38% | 83.69% | 25.09% | Upgrade
|
| Cost of Revenue | 2.19 | 2 | 2.65 | 3.05 | 8.45 | 3.63 | Upgrade
|
| Gross Profit | 1.73 | 1.79 | 1.44 | -0.5 | 3.88 | 3.09 | Upgrade
|
| Selling, General & Admin | 4.15 | 4.72 | 5.3 | 6.57 | 7.3 | 6.16 | Upgrade
|
| Research & Development | 0.66 | 0.62 | 0.24 | 0.6 | 1.41 | 0.82 | Upgrade
|
| Other Operating Expenses | 0.71 | 0.7 | 0.75 | 1.16 | -1.73 | 0.2 | Upgrade
|
| Operating Expenses | 7.07 | 7.63 | 7.94 | 10.23 | 8.98 | 8.49 | Upgrade
|
| Operating Income | -5.34 | -5.84 | -6.51 | -10.73 | -5.1 | -5.41 | Upgrade
|
| Interest Expense | -0.01 | -0.02 | -0.01 | -0.01 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.06 | 0.15 | 0.07 | 0.01 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.01 | 0.03 | 0.11 | 0.09 | -0.41 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.34 | 0.83 | 0.29 | 0.6 | -0.69 | -0.4 | Upgrade
|
| EBT Excluding Unusual Items | -3.98 | -4.97 | -6.05 | -9.96 | -5.71 | -6.13 | Upgrade
|
| Asset Writedown | - | - | -0.8 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.11 | Upgrade
|
| Pretax Income | -3.98 | -4.97 | -6.85 | -9.96 | -5.71 | -6.02 | Upgrade
|
| Net Income | -3.98 | -4.97 | -6.85 | -9.96 | -5.71 | -6.02 | Upgrade
|
| Net Income to Common | -3.98 | -4.97 | -6.85 | -9.96 | -5.71 | -6.02 | Upgrade
|
| Shares Outstanding (Basic) | 729 | 647 | 635 | 571 | 569 | 564 | Upgrade
|
| Shares Outstanding (Diluted) | 729 | 647 | 635 | 571 | 569 | 564 | Upgrade
|
| Shares Change (YoY) | 13.90% | 1.96% | 11.17% | 0.34% | 0.82% | 58.81% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | Upgrade
|
| Free Cash Flow | -2.23 | -1.99 | -4.7 | -5.91 | -4.2 | -7.35 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 44.10% | 47.28% | 35.16% | -19.71% | 31.47% | 45.96% | Upgrade
|
| Operating Margin | -136.19% | -153.90% | -159.22% | -421.68% | -41.30% | -80.50% | Upgrade
|
| Profit Margin | -101.45% | -131.08% | -167.57% | -391.46% | -46.26% | -89.66% | Upgrade
|
| Free Cash Flow Margin | -56.96% | -52.54% | -115.06% | -232.25% | -34.04% | -109.37% | Upgrade
|
| EBITDA | -4.46 | -4.69 | -5.27 | -9.25 | -3.63 | -4.46 | Upgrade
|
| EBITDA Margin | -113.85% | -123.79% | -129.00% | - | -29.45% | -66.36% | Upgrade
|
| D&A For EBITDA | 0.88 | 1.14 | 1.24 | 1.48 | 1.46 | 0.95 | Upgrade
|
| EBIT | -5.34 | -5.84 | -6.51 | -10.73 | -5.1 | -5.41 | Upgrade
|
| EBIT Margin | -136.19% | -153.90% | -159.22% | - | -41.30% | -80.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.